The purpose of this book-the fourth volume of a series on Can- cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can- cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can- cer, but also as increasingly important players in ...
Read More
The purpose of this book-the fourth volume of a series on Can- cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can- cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the publication of the last volume in this series. The 1980, 1982, and 1985 volumes covered the development of cancer markers, not only in their roles of unraveling the basic biology of can- cer, but also as increasingly important players in the management of patients with cancer. During the last 7 years we have seen the applica- tion of a number of markers identified by monoclonal antibodies, as well as the beginnings of the use of genetic markers defined by mo- lecular probes. Measurements of oncogenes in tissues or cells prom- ise many applications for the future, but as yet, these genes have not shown to be useful as serum markers of cancer. The commercial interest in serum markers for cancer, particu- larly for the diagnosis and monitoring of tumor patients, is indicated in Chapter 24 by Owen, where the total worldwide market for cancer markers is projected to increase from $148 million in 1988 to $232 million in 1993. The degree of research interest in cancer markers is reflected in the fact that in 1988 a separate category for tumor mark- ers was added to Index Medicus.
Read Less
Add this copy of Serological Cancer Markers to cart. $111.58, like new condition, Sold by GreatBookPrices rated 4.0 out of 5 stars, ships from Columbia, MD, UNITED STATES, published 2012 by Humana.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Trade paperback (US). Glued binding. 536 p. Contemporary Biomedicine, 11. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of Serological Cancer Markers to cart. $112.71, new condition, Sold by GreatBookPrices rated 4.0 out of 5 stars, ships from Columbia, MD, UNITED STATES, published 2012 by Humana.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Trade paperback (US). Glued binding. 536 p. Contemporary Biomedicine, 11. In Stock. 100% Money Back Guarantee. Brand New, Perfect Condition, allow 4-14 business days for standard shipping. To Alaska, Hawaii, U.S. protectorate, P.O. box, and APO/FPO addresses allow 4-28 business days for Standard shipping. No expedited shipping. All orders placed with expedited shipping will be cancelled. Over 3, 000, 000 happy customers.
Add this copy of Serological Cancer Markers to cart. $112.72, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2012 by Humana.
Add this copy of Serological Cancer Markers to cart. $126.76, new condition, Sold by booksXpress, ships from Bayonne, NJ, UNITED STATES, published 2012 by Humana.
Add this copy of Serological Cancer Markers to cart. $138.90, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 1992 by Humana Press.
